The Glucose-Regulated MiR-483-3p Influences Key Signaling Pathways in Cancer

miR-483-3p regulates acute myocardial infarction by transcriptionally repressing insulin growth factor 1 expression

(2018) Hao Sun et al.   Molecular Medicine Reports

Role of miR-483 in digestive tract cancers: from basic research to clinical value

(2018) Wei Zhou et al.   Journal of Cancer

MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma

(2017) Shaohui Tang et al.   Oncotarget

Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy

(2017) Łukasz Koperski et al.   Oncotarget

The HMGA1 Pseudogene 7 Induces miR-483 and miR-675 Upregulation by Activating Egr1 through a ceRNA Mechanism

(2017) Marco De Martino et al.   Genes

Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells

(2017) F Pepe et al.   Oncogenesis

miRNome Profiling of Purified Endoderm and Mesoderm Differentiated from hESCs Reveals Functions of miR-483-3p and miR-1263 for Cell-Fate Decisions

(2017) Daichi Ishikawa et al.   Stem Cell Reports

Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors

(2017) Pál Perge et al.   Scientific Reports

Identification of featured biomarkers in breast cancer with microRNA microarray

(2016) Ming Zhang et al.   ARCHIVES OF GYNECOLOGY AND OBSTETRICS

miR-483-3p regulates hyperglycaemia-induced cardiomyocyte apoptosis in transgenic mice

(2016) Yu Qiao et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Regulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival Mechanisms

(2016) Stefan Burén et al.   CANCER CELL

miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24

(2016) Jiaojiao Ma et al.   CELL BIOLOGY INTERNATIONAL

Elevated serum microRNA 483-5p levels may predict patients at risk of post-operative atrial fibrillation

(2016) Leanne Harling et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

miR-483 is a self-regulating microRNA and can activate its own expression via USF1 in HeLa cells

(2016) Verena Vanessa Emmerling et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Changes inO-LinkedN-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells

(2016) Rafaela Muniz de Queiroz et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Upregulation of miR-483-3p contributes to endothelial progenitor cells dysfunction in deep vein thrombosis patients via SRF

(2016) Lingshang Kong et al.   Journal of Translational Medicine

Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications

(2016) S. Di Mauro et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

PKC-alpha modulation by miR-483-3p in platinum-resistant ovarian carcinoma cells

(2016) Noemi Arrighetti et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Meta-analysis of the differentially expressed microRNA profiles in nasopharyngeal carcinoma

(2016) Junwen Luan et al.   Oncotarget

Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network

(2016) Yaqun Zhu et al.   Oncotarget

IGF2-derived miR-483 mediated oncofunction by suppressing DLC-1 and associated with colorectal cancer

(2016) Hengmi Cui et al.   Oncotarget

Temperature-sensitive miR-483 is a conserved regulator of recombinant protein and viral vector production in mammalian cells

(2015) Verena V. Emmerling et al.   BIOTECHNOLOGY AND BIOENGINEERING

Altered regulation of miR-34a and miR-483-3p in alcoholic hepatitis and DDC fed mice

(2015) Hui Liu et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma

(2015) Huanxi Xu et al.   TUMOR BIOLOGY

Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma

(2015) Cuiping Wang et al.   TUMOR BIOLOGY

Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus

(2015) Xin Dai et al.   Journal of Diabetes

MiRNA Profiles in Lymphoblastoid Cell Lines of Finnish Prostate Cancer Families

(2015) Daniel Fischer et al.   PLoS One

Plasma microRNA profiling of pediatric patients with immune thrombocytopenic purpura

(2014) Ali Bay et al.   BLOOD COAGULATION & FIBRINOLYSIS

miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM

(2014) Q. Song et al.   CANCER RESEARCH

Profiling Plasma MicroRNA in Nasopharyngeal Carcinoma with Deep Sequencing

(2014) H.-Y. Wang et al.   CLINICAL CHEMISTRY

O-GlcNAcylation stabilizes β-catenin through direct competition with phosphorylation at threonine 41

(2014) Stéphanie Olivier-Van Stichelen et al.   FASEB JOURNAL

Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer

(2014) MAKOTO ABUE et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Overexpression of miR-483-5p/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-β stimulated HSCs in transgenic mice

(2014) Fuyuan Li et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway

(2014) Qichao Huang et al.   JOURNAL OF HEPATOLOGY

Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin–angiotensin system

(2014) Jacqueline R. Kemp et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture

(2014) Xingnan Li et al.   NATURE MEDICINE

DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions

(2014) Ioannis S. Vlachos et al.   NUCLEIC ACIDS RESEARCH

Profiling of Serum and Urinary MicroRNAs in Children with Atopic Dermatitis

(2014) Yani Lv et al.   PLoS One

Genetic versus Non-Genetic Regulation of miR-103, miR-143 and miR-483-3p Expression in Adipose Tissue and Their Metabolic Implications—A Twin Study

(2014) Jette Bork-Jensen et al.   Genes

Tumor suppressor function of miR-483-3p on squamous cell carcinomas due to its pro-apoptotic properties

(2013) Thomas BERTERO et al.   CELL CYCLE

CDC25A targeting by miR-483-3p decreases CCND–CDK4/6 assembly and contributes to cell cycle arrest

(2013) T Bertero et al.   CELL DEATH AND DIFFERENTIATION

Tumors, IGF-2, and Hypoglycemia: Insights From the Clinic, the Laboratory, and the Historical Archive

(2013) Yevgeniya Dynkevich et al.   ENDOCRINE REVIEWS

IGF2 and cancer

(2013) Callum Livingstone   ENDOCRINE-RELATED CANCER

Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers

(2013) Cuiping Wang et al.   HISTOPATHOLOGY

Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways

(2013) Yasuhito Onodera et al.   JOURNAL OF CLINICAL INVESTIGATION

Radon-Induced Alterations in Micro-RNA Expression Profiles in Transformed BEAS2B Cells

(2013) Feng-Mei Cui et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES

p53/mdm2 Feedback Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma

(2013) Francesca Fornari et al.   MOLECULAR CANCER RESEARCH

Tumour heterogeneity and cancer cell plasticity

(2013) Corbin E. Meacham et al.   NATURE

NAFLD, NASH and liver cancer

(2013) Gregory A. Michelotti et al.   Nature Reviews Gastroenterology & Hepatology

miRBase: annotating high confidence microRNAs using deep sequencing data

(2013) Ana Kozomara et al.   NUCLEIC ACIDS RESEARCH

MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma

(2013) Xiaotang Yu et al.   TUMOR BIOLOGY

IGF-1 promotes the development and cytotoxic activity of human NK cells

(2013) Fang Ni et al.   Nature Communications

Identification of a pathway by which glucose regulates β-catenin signalling via the cAMP/protein kinase A pathway in β-cell models

(2012) Emmanuelle Cognard et al.   BIOCHEMICAL JOURNAL

MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma

(2012) Wen Wang et al.   CARCINOGENESIS

Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes

(2012) D Ferland-McCollough et al.   CELL DEATH AND DIFFERENTIATION

Widespread plasticity in CTCF occupancy linked to DNA methylation

(2012) H. Wang et al.   GENOME RESEARCH

Serum miR-483-5p as a potential biomarker to detect hepatocellular carcinoma

(2012) Zhoujing Zhang et al.   Hepatology International

MicroRNAs in the Pineal Gland

(2012) Samuel J. H. Clokie et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Four serum microRNAs identified as diagnostic biomarkers of sepsis

(2012) Hui-juan Wang et al.   Journal of Trauma and Acute Care Surgery

TET2 promotes histone O-GlcNAcylation during gene transcription

(2012) Qiang Chen et al.   NATURE

Comprehensive molecular characterization of human colon and rectal cancer

(2012)   NATURE

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

(2012) Cécile Guichard et al.   NATURE GENETICS

MiR-663, a microRNA targeting p21 WAF1/CIP1 , promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma

(2012) C Yi et al.   ONCOGENE

Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop

(2012) J Zhang et al.   ONCOGENE

Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma

(2012) Wen Wang   WORLD JOURNAL OF GASTROENTEROLOGY

The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of β-catenin and cell proliferation

(2011) Stéphanie Olivier-Van Stichelen et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

p53 and c-myc: How does the cell balance “yin” and “yang”?

(2011) Mohit Sachdeva et al.   CELL CYCLE

miR-483-3p controls proliferation in wounded epithelial cells

(2011) Thomas Bertero et al.   FASEB JOURNAL

Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells

(2011) D Kong et al.   ONCOGENE

Mutated  -catenin evades a microRNA-dependent regulatory loop

(2011) A. Veronese et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1

(2011) William CS Cho et al.   RNA Biology

MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy

(2010) Erin E. Patterson et al.   CANCER

Oncogenic Role of miR-483-3p at the IGF2/483 Locus

(2010) A. Veronese et al.   CANCER RESEARCH

MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures

(2010) M Zuntini et al.   CLINICAL GENETICS

MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets

(2010) Goswin Y Meyer-Rochow et al.   ENDOCRINE-RELATED CANCER

MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer

(2010) Jun Hao et al.   FEBS LETTERS

Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation

(2010) Qianghua Hu et al.   JOURNAL OF CLINICAL INVESTIGATION

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

(2010) Chun-Zhi Zhang et al.   Molecular Cancer

miRBase: integrating microRNA annotation and deep-sequencing data

(2010) A. Kozomara et al.   NUCLEIC ACIDS RESEARCH

O-linked β-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress

(2009) Chutikarn Butkinaree et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring

(2009) Junlong Zhang et al.   BMC GENOMICS

miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation

(2009) Michela Garofalo et al.   CANCER CELL

MicroRNA-145 Suppresses Cell Invasion and Metastasis by Directly Targeting Mucin 1

(2009) M. Sachdeva et al.   CANCER RESEARCH

MicroRNA-145 Regulates OCT4, SOX2, and KLF4 and Represses Pluripotency in Human Embryonic Stem Cells

(2009) Na Xu et al.   CELL

miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells

(2009) R Spizzo et al.   CELL DEATH AND DIFFERENTIATION

Uncovering Growth-Suppressive MicroRNAs in Lung Cancer

(2009) X. Liu et al.   CLINICAL CANCER RESEARCH

CDKN2A,NF2, andJUNare dysregulated among other genes by miRNAs in malignant mesothelioma-A miRNA microarray analysis

(2009) Mohamed Guled et al.   GENES CHROMOSOMES & CANCER

MicroRNAs in Cancer: Small Molecules With a Huge Impact

(2009) Marilena V. Iorio et al.   JOURNAL OF CLINICAL ONCOLOGY

Modulation of microRNA processing by p53

(2009) Hiroshi I. Suzuki et al.   NATURE

Proteomic analysis of β-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway

(2009) Philippe Chafey et al.   PROTEOMICS

Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance

(2008) Xiaoyong Yang et al.   NATURE

The H19 locus acts in vivo as a tumor suppressor

(2008) T. Yoshimizu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA